Halozyme Therapeutics Inc (NAS:HALO)
$ 59.26 -0.26 (-0.44%) Market Cap: 7.51 Bil Enterprise Value: 8.48 Bil PE Ratio: 22.97 PB Ratio: 25.91 GF Score: 87/100

Halozyme Therapeutics Inc (HALO) Transcripts

  • 1